Tenet Healthcare Corporation (THC)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NYSE
Market Cap: $22.76B
Last updated: Nov 17, 2026 at 11:06 AM ET
Tenet Healthcare Corporation (THC) Financials: Revenue, Profit and Cash Flow
Tenet Healthcare reported revenue of $21.31B for the fiscal year ended Dec 31, 2025, up 3.1% from the year before. That year, net income was $2.37B with a net margin of 11.1%, operating cash flow was $3.54B and free cash flow was $2.53B. The quarter ended Sep 30, 2026 had revenue of $5.63B and net income of $1.22B.
Revenue and Margins
The operating margin was 16.5% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $21.07B, a compound annual rate of 0.1%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $21.31B | +3.1% | 59.2% | 16.5% | 11.1% |
| Dec 2024 | $20.68B | +0.5% | 57.4% | 28.8% | 19.7% |
| Dec 2023 | $20.56B | +6.2% | 55.5% | 12.2% | 6.4% |
| Dec 2022 | $19.37B | +10040.3% | 54.3% | 12.0% | 5.2% |
| Dec 2021 | $191.00M | -99.0% | 3911.0% | 1389.0% | 772.8% |
| Dec 2020 | $18.52B | +0.2% | 38.5% | 9.8% | 4.1% |
| Dec 2019 | $18.48B | +0.9% | 52.9% | 8.3% | 0.9% |
| Dec 2018 | $18.31B | -11.2% | 36.5% | 8.1% | 2.5% |
| Dec 2017 | $20.61B | -2.2% | 33.1% | 4.7% | -1.6% |
| Dec 2016 | $21.07B | N/A | 34.0% | 5.3% | 0.8% |
Income Statement
In the fiscal year ended Dec 2025, net income fell 41.6% from the year before. In the quarter ended Sep 2026, net income rose 110.7% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $21.31B | $20.68B | $20.56B | $19.37B | $191.00M | $18.52B | $18.48B | $18.31B | $20.61B | $21.07B |
| Cost of revenue | $8.71B | $8.80B | $9.15B | $8.84B | -$7.28B | $11.40B | $8.70B | $11.64B | $13.79B | $13.90B |
| Gross profit | $12.61B | $11.87B | $11.42B | $10.52B | $7.47B | $7.12B | $9.78B | $6.68B | $6.82B | $7.17B |
| Operating income | $3.51B | $5.96B | $2.51B | $2.33B | $2.65B | $1.82B | $1.54B | $1.49B | $969.00M | $1.12B |
| Net income | $2.37B | $4.06B | $1.31B | $1.00B | $1.48B | $768.00M | $171.00M | $459.00M | -$320.00M | $176.00M |
| EBITDA | $4.51B | $6.93B | $3.43B | $3.22B | $3.56B | $2.72B | $2.42B | $2.33B | $1.86B | $1.99B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.63B | $5.63B | $5.37B | $5.53B | $5.29B | $5.27B | $5.22B | $5.07B | $5.13B | $5.11B | $5.37B | $5.38B |
| Gross profit | $3.46B | $3.40B | $3.19B | $3.31B | $3.08B | $3.11B | $3.10B | $2.98B | $2.91B | $2.94B | $3.05B | $4.85B |
| Operating income | $1.75B | $1.50B | $1.30B | $853.00M | $889.00M | $823.00M | $943.00M | $821.00M | $1.09B | $761.00M | $3.29B | $789.00M |
| Net income | $1.22B | $1.04B | $906.00M | $644.00M | $579.00M | $522.00M | $622.00M | $572.00M | $681.00M | $477.00M | $2.33B | $456.00M |
Balance Sheet
As of Dec 2025, total debt of $13.17B exceeded cash and equivalents by $10.29B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $29.68B | $28.94B | $28.31B | $27.16B | $27.58B | $27.11B | $23.36B | $22.41B | $23.39B | $24.70B |
| Current assets | $7.85B | $7.68B | $7.17B | $5.98B | $7.08B | $7.15B | $5.08B | $4.64B | $5.57B | $5.26B |
| Cash and equivalents | $2.88B | $3.02B | $1.23B | $858.00M | $2.36B | $2.45B | $262.00M | $411.00M | $611.00M | $716.00M |
| Total liabilities | $20.70B | $20.39B | $22.80B | $22.55B | $23.32B | $24.22B | $21.42B | $20.30B | $20.98B | $21.23B |
| Short-term debt | $79.00M | $92.00M | $120.00M | $145.00M | $135.00M | $145.00M | $171.00M | $182.00M | $146.00M | $191.00M |
| Long-term debt | $13.09B | $13.08B | $14.88B | $14.93B | $15.51B | $15.57B | $14.58B | $14.64B | $14.79B | $15.06B |
| Shareholder equity | $4.22B | $4.17B | $1.61B | $1.14B | $1.03B | $28.00M | -$417.00M | -$119.00M | -$147.00M | $417.00M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $31.59B | $30.68B | $31.20B | $29.68B | $29.42B | $28.70B | $29.24B | $28.94B | $29.37B | $29.27B | $28.91B | $28.31B |
| Total liabilities | $22.00B | $21.98B | $22.35B | $20.70B | $20.72B | $20.40B | $20.58B | $20.39B | $21.30B | $21.40B | $21.24B | $22.80B |
| Cash and equivalents | $2.67B | $2.17B | $2.97B | $2.88B | $2.98B | $2.63B | $3.00B | $3.02B | $4.09B | $2.88B | $2.48B | $1.23B |
| Shareholder equity | $5.44B | $4.66B | $4.81B | $4.22B | $4.01B | $3.75B | $4.18B | $4.17B | $3.83B | $3.48B | $3.45B | $1.61B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 71.5% of operating cash flow. Dividends and share repurchases together came to 90.5% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $3.54B | $2.05B | $2.37B | $1.08B | $1.57B | $3.41B | $1.23B | $1.05B | $1.20B | $558.00M |
| Capital expenditures | $1.01B | $931.00M | $751.00M | $762.00M | $658.00M | $540.00M | $670.00M | $617.00M | $707.00M | $875.00M |
| Free cash flow | $2.53B | $1.12B | $1.62B | $321.00M | $910.00M | $2.87B | $563.00M | $432.00M | $493.00M | -$317.00M |
| Dividends paid | $901.00M | $881.00M | $761.00M | $660.00M | $450.00M | $326.00M | $318.00M | $935.00M | $987.00M | $404.00M |
| Share repurchases | $1.39B | $672.00M | $200.00M | $250.00M | $0 | $0 | N/A | N/A | N/A | N/A |
| Investing cash flow | -$1.27B | $3.43B | -$969.00M | -$808.00M | -$714.00M | -$1.61B | -$619.00M | -$115.00M | $21.00M | -$430.00M |
| Financing cash flow | -$2.40B | -$3.69B | -$1.03B | -$1.78B | -$936.00M | $385.00M | -$763.00M | -$1.13B | -$1.33B | $232.00M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.28B | $585.00M | $1.64B | $731.00M | $1.06B | $936.00M | $815.00M | -$331.00M | $1.04B | $747.00M | $586.00M | $824.00M |
| Capital expenditures | $198.00M | $168.00M | $180.00M | $364.00M | $280.00M | $193.00M | $173.00M | $330.00M | $216.00M | $145.00M | $240.00M | $208.00M |
| Free cash flow | $1.08B | $417.00M | $1.46B | $367.00M | $778.00M | $743.00M | $642.00M | -$661.00M | $829.00M | $602.00M | $346.00M | $616.00M |
Frequently Asked Questions About THC
What is Tenet Healthcare's annual revenue?
Tenet Healthcare reported revenue of $21.31B for the fiscal year ended Dec 31, 2025.
How fast is Tenet Healthcare's revenue growing?
Revenue was up 3.1% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 3.2%.
Is Tenet Healthcare profitable?
Yes. Tenet Healthcare reported net income of $2.37B for the fiscal year ended Dec 31, 2025, with a net margin of 11.1%.
How much free cash flow does THC generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $3.54B minus capital expenditures of $1.01B produced free cash flow of $2.53B.
How much debt does Tenet Healthcare have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $13.09B, short-term debt of $79.00M and cash and equivalents of $2.88B.
THC pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts